Showing 1 - 5 results of 5 for search 'María Dolores Torregrosa', query time: 0.04s
Refine Results
-
1
Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated wi... by Javier García-Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa, Omar Cauli
Published 2022-07-01
Article -
2
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study by Javier García-Sánchez, Mayra Alejandra Mafla-España, María Dolores Torregrosa, Omar Cauli
Published 2022-12-01
Article -
3
Impact of a Physical Exercise and Health Education Program on Metabolic Syndrome and Quality of Life in Postmenopausal Breast Cancer Women Undergoing Adjuvant Treatment with Aromat... by Pedro Cespedes, Francisco M. Martínez-Arnau, María Dolores Torregrosa, Omar Cauli, Cristina Buigues
Published 2024-11-01
Article -
4
Plasma Androstenedione Concentration Can Discriminate Frail versus Non-Frail Men with Prostate Cancer under Androgen Deprivation Therapy by Mayra Alejandra Mafla-España, María Dolores Torregrosa, Manel Beamud-Cortés, Lorena Bermell-Marco, José Rubio-Briones, Omar Cauli
Published 2023-11-01
Article -
5
Plasma Aromatase Activity Index, Gonadotropins and Estrone Are Associated with Frailty Syndrome in Post-Menopausal Women with Breast Cancer by Javier García-Sánchez, Mayra Alejandra Mafla-España, Carlos Tejedor-Cabrera, Olga Avellán-Castillo, María Dolores Torregrosa, Omar Cauli
Published 2022-03-01
Article